{"id":"https://openalex.org/W2558092778","doi":"https://doi.org/10.1182/blood.v104.11.4307.4307","title":"Distinct Biological Impact of Dephosphorylation vs Downregulation of p210Bcr-Abl: Implications for Imatinib Mesylate Response and Resistance.","display_name":"Distinct Biological Impact of Dephosphorylation vs Downregulation of p210Bcr-Abl: Implications for Imatinib Mesylate Response and Resistance.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2558092778","doi":"https://doi.org/10.1182/blood.v104.11.4307.4307","mag":"2558092778"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.4307.4307","doi":"https://doi.org/10.1182/blood.v104.11.4307.4307","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.4307.4307","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":["Phase I Program, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Program, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011529063","display_name":"Moshe Talpaz","orcid":"https://orcid.org/0000-0003-3361-3981","observed_orcids":["https://orcid.org/0000-0003-3361-3981"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Moshe Talpaz","raw_affiliation_strings":["Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lan Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lan Li","raw_affiliation_strings":["Phase I Program, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase I Program, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084290698","display_name":"Zeev E. Estrov","orcid":"https://orcid.org/0000-0002-1623-3613","observed_orcids":["https://orcid.org/0000-0002-1623-3613"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zeev Estrov","raw_affiliation_strings":["Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.31916197,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"4307","last_page":"4307"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p210-bcr-abl","display_name":"p210 BCR-ABL","score":0.9160000085830688},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia-blast-crisis","display_name":"chronic myeloid leukemia blast crisis","score":0.9359999895095825},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.949999988079071},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.8870000243186951},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9559999704360962},{"id":"https://openalex.org/keywords/growth-factor-signaling","display_name":"growth factor signaling","score":0.7229999899864197}],"concepts":[{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.9375007152557373},{"id":"https://openalex.org/C125418893","wikidata":"https://www.wikidata.org/wiki/Q587961","display_name":"ABL","level":4,"score":0.5790631175041199},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5700302720069885},{"id":"https://openalex.org/C171122931","wikidata":"https://www.wikidata.org/wiki/Q6324626","display_name":"K562 cells","level":3,"score":0.49425366520881653},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.48458707332611084},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.4439897835254669},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.4394417107105255},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.43700000643730164},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.31279540061950684},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.2433604598045349},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.23622000217437744},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.16968947649002075},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.1448356807231903},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05738335847854614},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.4307.4307","doi":"https://doi.org/10.1182/blood.v104.11.4307.4307","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.4307.4307","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979453157","https://openalex.org/W2075155467","https://openalex.org/W2979702269","https://openalex.org/W1504722631","https://openalex.org/W7160393842","https://openalex.org/W2166342674","https://openalex.org/W2135160560","https://openalex.org/W2081284522","https://openalex.org/W7220695781","https://openalex.org/W2574160086"],"abstract_inverted_index":{"Abstract":[0],"Imatinib":[1],"mesylate":[2,26,56,75,198],"acts":[3],"by":[4,139],"suppressing":[5],"phosphorylation":[6],"of":[7,17,84,95,133,147,159,165,176,178,184,187,190],"its":[8],"kinase":[9,20,102,192],"target":[10,189],"-":[11,98],"Bcr-Abl.":[12],"We":[13,161],"hypothesized":[14],"that":[15,119,163,175],"loss":[16,186],"p210Bcr-Abl":[18,59,113,134,168,179],"(the":[19],"target)":[21],"may":[22,126,135,194],"lead":[23,195],"to":[24,54,73,196],"imatinib":[25,55,74,141,151,197],"resistance.":[27,199],"Two":[28],"model":[29],"systems":[30],"were":[31,66,90,110],"studied:":[32],"K562":[33,64],"cells":[34,41,44,47,65],"(CML":[35],"blast":[36,154],"crisis":[37,155],"line)":[38],"and":[39,100],"MO7E/MBA-1":[40],"(with":[42],"MBA-1":[43],"representing":[45],"MO7E":[46],"stably":[48],"transfected":[49],"with":[50,128,150],"BCR-ABL).":[51],"Relative":[52],"resistance":[53],"developed":[57],"when":[58,112],"expression":[60,97],"was":[61,114],"abolished.":[62],"Furthermore,":[63],"significantly":[67],"more":[68],"growth":[69,106],"suppressed":[70],"after":[71,82],"exposure":[72],"(p210Bcr-Abl":[76],"is":[77],"present":[78,115],"but":[79,116,122],"dephosphorylated),":[80],"than":[81],"downregulation":[83],"Bcr-Abl":[85,96],"expression.":[86],"Signaling":[87],"pathways":[88],"which":[89,140],"functional":[91],"in":[92,181],"the":[93,105,188,191],"absence":[94],"NF-KB":[99],"MAP":[101],"activation":[103],"or":[104],"factor":[107],"pathway":[108],"--":[109],"disrupted":[111],"dephosphorylated,":[117],"suggesting":[118],"an":[120],"intact,":[121],"enzymatically":[123],"inactive":[124],"Bcr-Abl,":[125],"interfere":[127],"critical":[129],"growth/signaling":[130],"pathways.":[131],"Downregulation":[132],"be":[136],"a":[137,166,170,182],"mechanism":[138],"mesylate-resistance":[142],"emerges.":[143],"Samples":[144],"from":[145,174],"3":[146],"15":[148],"patients":[149],"mesylate-resistant":[152],"CML":[153],"had":[156],"undetectable":[157],"levels":[158],"p210Bcr-Abl.":[160],"conclude":[162],"retention":[164],"dephosphorylated":[167],"has":[169],"biologic":[171],"impact":[172],"distinct":[173],"downregulation/loss":[177],"and,":[180],"subset":[183],"patients,":[185],"inhibitor":[193]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-12-08T00:00:00"}